Evaluasi Efektivitas Vaksin Covid-19 AstraZeneca Setelah 6 Bulan Dosis Kedua

Ningsih, Windi Marti (2022) Evaluasi Efektivitas Vaksin Covid-19 AstraZeneca Setelah 6 Bulan Dosis Kedua. Diploma thesis, Universitas 17 agustus 1945.

Text Naskah Jurnal Windi Marti Ningsih (1843050024) - Salin.pdf Restricted to Registered users only Download (550kB)

Abstract

Growing efforts are being made to socialize the vaccination program in order to establish a global herd immunity. In clinical trials of strategy and development, the astrazeneca vaccine's efficacy is a crucial concern. The purpose of this study was to evaluated the effectiveness of Astrazeneca’s Covid-19 vaccine after 6 months of the second dose. This study was conducted to evaluate the effectiveness of the Astrazeneca vaccine after 6 months of the second dose in Indonesian people. This type of research is observational with a cross sectional design. This method is done by direct observation of the survey data. This research requires ethical approval No.40/KEPK-UTA45JKT/EC/EXP/07/2022. The results of this study showed that there was a significant relationship between sociodemography and the incidence of COVID-19 infection after administration of the AstraZeneca vaccine such as gender, age, and BMI. The most common side effect of receiving AstraZeneca is pain at the injection site. The effectiveness of the astrazeneca vaccine can be seen from the average not exposed to covid-19, which is 95% where the Covid-19 vaccine in this study is safe for gender and age > 18 years.

Actions (login required)

View Item